Drug recall · October 27, 2021
Rocuronium Bromide Injection 50mg/5 mL recall
Why: Labeling: Label Lacks Warning or Rx Legend: Finished product did not include the statement on the flip cap vial, "WARNING: PARALYZING AGENT"
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Rocuronium Bromide Injection 50mg/5 mL, 5mL Multi-Dose Vial, Rx only, Manufactured for: Piramal Critical Care, Bethlehem, PA 18017, USA, Manufactured by: Sanovel Ilac, San. Ve Tic. A.S. Istanbul, Turkey, NDC 66794-0228-41
- Lots / codes
Lot #: 20415001, 20415002, Expiration Date 05/2022
- Quantity
- 100 glass vials
- Company
- Piramal Critical Care, Inc., Bethlehem, PA
- Distribution
- Nationwide within the United States
- Initiated
- September 10, 2021 · Voluntary: Firm initiated
- Classified
- October 20, 2021
- Reported
- October 27, 2021
- Ended
- September 7, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Rocuronium
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.